Quest Products is looking to break onto the external analgesic scene with CopperFixx, a balm that combines the analgesic properties associated with copper and arnica. Other brands continuing to lead the way were Blue Emu ($28.6 million, up 20.1%), Australian Dream ($23.1 million, up 20.7%) and Boiron’s Arincare ($19.1 million, up 19.7%).
Pfizer’s Nexium 24HR is the clear leader in the digestive aisle. However, in March 2017, store-brand versions of Nexium 24HR will be available. Perrigo has already secured a tentative approval from the Food and Drug Administration for its OTC Nexium 24HR generic equivalent.
Target Corp. on Wednesday reported second quarter earnings that exceeded Wall Street expectations, but the discounter lowered its guidance for the full year amid declining sales and what it called a “difficult retail environment.”
Bausch + Lomb introduced a new and improved PreserVision AREDS 2 Formula + Multivitamin, one of the better selling vitamins on the shelf with $135.1 million in sales on 19.6% growth across total U.S. multi-outlets, according to IRI.